Improvement in das28 response through 1-yr of golimumab treatment in pts with active RA despite treatment with MTX: A randomized, double blind, placebo-controlled, dose-ranging trial

Dasgupta, B.; Durez, Patrick; Kay, J.; Matteson, E. L.; Nash, P.; Hall, S.; Hsia, E. C.; Chiruvolu, P.; Han, J.; Rahman, M.

Improvement in das28 response through 1-yr of golimumab treatment in pts with active RA despite treatment with MTX: A randomized, double blind, placebo-controlled, dose-ranging trial

Dasgupta, B.

;

Durez, Patrick

;

Kay, J.

;

Matteson, E. L.

;

Rahman, M.

;et.al.

(2008) Annual Meeting of the British-Society-Rheumatology/Spring Meeting of British Health Professional in Rheumatology — Location: Liverpool (England) (22.April.2007)

Files

No attached file found for this publication.

Details

Authors

Dasgupta, B.
Author
Durez, PatrickUCLouvain
Author
Kay, J.
Author
Matteson, E. L.
Author
Rahman, M.
Author

Affiliations

Citations

APA
Chicago
FWB

Dasgupta, B., Durez, P., Kay, J., Matteson, E. L., Nash, P., Hall, S., Hsia, E. C., Chiruvolu, P., Han, J., & Rahman, M. (2008). Improvement in das28 response through 1-yr of golimumab treatment in pts with active RA despite treatment with MTX: A randomized, double blind, placebo-controlled, dose-ranging trial. Rheumatology (Print), 47, II50-II51. https://hdl.handle.net/2078.5/67011 (Original work published 2008)